![]() Midatech Pharma Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines. | ![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ![]() Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. | |
Founding Date | Founding Date 2000 | Founding Date 2006 | Founding Date 1994 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Cardiff, GB HQ Milton, GB | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Newark, US HQ |
Employees | Employees 8414% increase | Employees 39 | Employees 781% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) N/A |
Net income | Net income (£6.4m) (FY, 2025) | Net income (£2.6m) (FY, 2018) | Net income N/A |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 9.4m (over 12 years ago) | Latest funding round $ 10m (almost 16 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 57.3m | Total funding raised $ 37m |

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View company